Investec Bank Plc has filed a Form 8.5 regulatory disclosure revealing substantial share dealings in Advanced Medical Solutions Group Plc (AMS.L).
The disclosure, filed on 20th August 2026, relates to trading activity that took place on 19th August 2026 under the UK Takeover Code.
Investec Bank Plc holds the role of Advisor and Joint Broker to Advanced Medical Solutions Group Plc, giving it exempt principal trader status with recognised intermediary status.
Under Rule 8.5 of the Takeover Code, firms dealing in a client-serving capacity are required to publicly disclose their trading activity in relevant securities.
The filing reveals that Investec purchased a total of 338,546 ordinary shares in Advanced Medical Solutions Group at prices ranging from 280.75p to 281.5p per unit.
Simultaneously, Investec sold an equivalent number of 338,546 ordinary shares, with prices ranging between 281p and 281.5p per unit.
The matched volume of purchases and sales reflects Investec’s role as a market intermediary acting in a client-serving capacity rather than taking a proprietary position.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this regulatory filing.
Investec confirmed there are no indemnity arrangements, option agreements, or any formal or informal understandings that could serve as an inducement to deal or refrain from dealing.
Similarly, no agreements or understandings relating to voting rights or future acquisition and disposal of relevant securities through derivatives were disclosed by the bank.
The contact named in the disclosure is Priyali Bhattacharjee, reachable by telephone for any enquiries related to the filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure market transparency.
